BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 18310291)

  • 1. Defining molecular classifications and targets in gastroenteropancreatic neuroendocrine tumors through DNA microarray analysis.
    Duerr EM; Mizukami Y; Ng A; Xavier RJ; Kikuchi H; Deshpande V; Warshaw AL; Glickman J; Kulke MH; Chung DC
    Endocr Relat Cancer; 2008 Mar; 15(1):243-56. PubMed ID: 18310291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of membrane proteins in primary and metastatic gastrointestinal neuroendocrine tumors.
    Carr JC; Sherman SK; Wang D; Dahdaleh FS; Bellizzi AM; O'Dorisio MS; O'Dorisio TM; Howe JR
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3(0 3):S739-S746. PubMed ID: 24114056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences between Well-Differentiated Neuroendocrine Tumors and Ductal Adenocarcinomas of the Pancreas Assessed by Multi-Omics Profiling.
    Starzyńska T; Karczmarski J; Paziewska A; Kulecka M; Kuśnierz K; Żeber-Lubecka N; Ambrożkiewicz F; Mikula M; Kos-Kudła B; Ostrowski J
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32586046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of NeuroD and mASH1 in the gastroenteropancreatic neuroendocrine tumors.
    Shida T; Furuya M; Kishimoto T; Nikaido T; Tanizawa T; Koda K; Oda K; Takano S; Kimura F; Shimizu H; Yoshidome H; Ohtsuka M; Nakatani Y; Miyazaki M
    Mod Pathol; 2008 Nov; 21(11):1363-70. PubMed ID: 18587321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear survivin is a powerful novel prognostic marker in gastroenteropancreatic neuroendocrine tumor disease.
    Grabowski P; Griss S; Arnold CN; Hörsch D; Göke R; Arnold R; Heine B; Stein H; Zeitz M; Scherübl H
    Neuroendocrinology; 2005; 81(1):1-9. PubMed ID: 15809513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary Carcinoids and Low-Grade Gastrointestinal Neuroendocrine Tumors Show Common MicroRNA Expression Profiles, Different from Adenocarcinomas and Small Cell Carcinomas.
    Yoshimoto T; Motoi N; Yamamoto N; Nagano H; Ushijima M; Matsuura M; Okumura S; Yamaguchi T; Fukayama M; Ishikawa Y
    Neuroendocrinology; 2018; 106(1):47-57. PubMed ID: 28208131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NESP55, a novel chromogranin-like peptide, is expressed in endocrine tumours of the pancreas and adrenal medulla but not in ileal carcinoids.
    Jakobsen AM; Ahlman H; Kölby L; Abrahamsson J; Fischer-Colbrie R; Nilsson O
    Br J Cancer; 2003 Jun; 88(11):1746-54. PubMed ID: 12771991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Updates on Neuroendocrine Tumors From the Gastrointestinal and Pancreatobiliary Tracts.
    Kim JY; Hong SM
    Arch Pathol Lab Med; 2016 May; 140(5):437-48. PubMed ID: 27128301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High VEGF serum values are associated with locoregional spread of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
    Cigrovski Berković M; Čačev T; Catela Ivković T; Marout J; Ulamec M; Zjačić-Rotkvić V; Kapitanović S
    Mol Cell Endocrinol; 2016 Apr; 425():61-8. PubMed ID: 26805636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of World Health Organization 2000/2004 and World Health Organization 2010 classifications for gastrointestinal and pancreatic neuroendocrine tumors.
    Pasaoglu E; Dursun N; Ozyalvacli G; Hacihasanoglu E; Behzatoglu K; Calay O
    Ann Diagn Pathol; 2015 Apr; 19(2):81-7. PubMed ID: 25702616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-iodobenzylguanidine induces growth inhibition and apoptosis of neuroendocrine gastrointestinal tumor cells.
    Höpfner M; Sutter AP; Beck NI; Barthel B; Maaser K; Jockers-Scherübl MC; Zeitz M; Scherübl H
    Int J Cancer; 2002 Sep; 101(3):210-6. PubMed ID: 12209970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression accurately distinguishes liver metastases of small bowel and pancreas neuroendocrine tumors.
    Sherman SK; Maxwell JE; Carr JC; Wang D; Bellizzi AM; Sue O'Dorisio M; O'Dorisio TM; Howe JR
    Clin Exp Metastasis; 2014 Dec; 31(8):935-44. PubMed ID: 25241033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis.
    Ito T; Igarashi H; Nakamura K; Sasano H; Okusaka T; Takano K; Komoto I; Tanaka M; Imamura M; Jensen RT; Takayanagi R; Shimatsu A
    J Gastroenterol; 2015 Jan; 50(1):58-64. PubMed ID: 24499825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated clinicopathological features and gene microarray analysis of pancreatic neuroendocrine tumors.
    Zhou H; Chen Q; Tan W; Qiu Z; Li S; Song Y; Gao S
    Gene; 2017 Aug; 625():72-77. PubMed ID: 28479381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
    Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R
    Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P53, KI-67, CD117 expression in gastrointestinal and pancreatic neuroendocrine tumours and evaluation of their correlation with clinicopathological and prognostic parameters.
    Kımıloğlu Şahan E; Erdoğan N; Ulusoy İ; Samet E; Akyıldız İğdem A; Gönüllü D
    Turk J Gastroenterol; 2015 Mar; 26(2):104-11. PubMed ID: 25835106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genes involved in neuroendocrine tumor biology.
    Hofsli E
    Pituitary; 2006; 9(3):165-78. PubMed ID: 17001466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site- and grade-specific diversity of LINE1 methylation pattern in gastroenteropancreatic neuroendocrine tumours.
    Stricker I; Tzivras D; Nambiar S; Wulf J; Liffers ST; Vogt M; Verdoodt B; Tannapfel A; Mirmohammadsadegh A
    Anticancer Res; 2012 Sep; 32(9):3699-706. PubMed ID: 22993308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highlights of the biology of endocrine tumours of the gut and pancreas.
    Rindi G; Bordi C
    Endocr Relat Cancer; 2003 Dec; 10(4):427-36. PubMed ID: 14713255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cocaine- and amphetamine-regulated transcript in neuroendocrine tumors.
    Landerholm K; Falkmer SE; Järhult J; Sundler F; Wierup N
    Neuroendocrinology; 2011; 94(3):228-36. PubMed ID: 21832817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.